| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
 | 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
CIRCADIAN TECHNOLOGIES LIMITED (CIR)
Stock Code: CIR
Listing Date: 1991-04-18 00:00:00
Website: http://www.circadian.com.au
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Management and funding of pharmaceutical research and development projects with Australian and NZ Universities. Activities also include investment in leading edge Australian technology.
Address:
10 Wallace Avenue, Level 1
TOORAK
VIC 3142
Phone: (03) 9826 0399
Fax: (03) 9824 0083
Executives & Directors
Ms Dominique Fisher, Chairman, Non Exec. Director
Mr Robert Klupacs, Managing Director, CEO
Mr Don Clarke, Non Exec. Director
Ms Tina McMeckan, Non Exec. Director
Mr Carlo Montagner, Non Exec. Director
Ms Natalie Korchev, Company Secretary
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
Company Events
| Annual General Meeting | Fri, 14 Nov 2008 09:30AM |
|
| Full Year Results | Tue, 14 Oct 2008 | |
| Interim Results | Thu, 14 Feb 2008 | |
| Annual General Meeting | Thu, 25 Oct 2007 09:00AM |
|
| Full Year Results | Tue, 14 Aug 2007 | |
| Interim Results | Tue, 13 Feb 2007 | |
| Annual General Meeting | Fri, 27 Oct 2006 09:00AM |
|
| Full Year Results | Mon, 28 Aug 2006 | |
| Interim Results | Fri, 10 Feb 2006 | |
| Annual General Meeting | Thu, 6 Oct 2005 09:00AM |
|
| Date Payable | Thu, 24 Feb 2005 | |
| Record Date | Thu, 10 Feb 2005 | |
| Ex Div Date | Fri, 4 Feb 2005 |
CIRCADIAN TECHNOLOGIES LIMITED (CIR)
| Managing Director`s AGM Presentation | Fri, 14 Nov 2008 |
| Results of Annual General Meeting | Fri, 14 Nov 2008 |
| Final Director`s Interest Notice | Fri, 14 Nov 2008 |
| Open Briefing - CEO on VEGFR-3 Drug Development Candidate | Thu, 16 Oct 2008 |
| CIR CEO to present at Wilson HTM`s Life Sciences Conference | Wed, 15 Oct 2008 |
| ASX Waiver from Listing Rule 7.3.2 | Tue, 14 Oct 2008 |
| Notice of Annual General Meeting/Proxy Form | Tue, 14 Oct 2008 |
| Annual Report 2008 | Tue, 14 Oct 2008 |
| Licensee ImClone designates drug development candidate | Tue, 14 Oct 2008 |
| Dr John Stocker to retire as a director after the AGM | Fri, 10 Oct 2008 |
| AAH: Arana Completes a Series of Antibodies for Vegenics | Thu, 2 Oct 2008 |
| Arana completes humanisation of antibody for Vegenics | Thu, 2 Oct 2008 |
| Appendix 3B | Thu, 18 Sep 2008 |
| Circadian Newsletter - September 2008 | Thu, 11 Sep 2008 |
| Response to an ASX Query - Director`s Interest Notice | Fri, 5 Sep 2008 |
| Change of Director`s Interest Notice | Mon, 1 Sep 2008 |
| Preliminary Final Report | Fri, 22 Aug 2008 |
| Open Briefing - CEO on Drug Development Strategy | Mon, 18 Aug 2008 |
| Change in substantial holding | Fri, 15 Aug 2008 |
| Initial Director`s Interest Notice | Fri, 15 Aug 2008 |
| Becoming a substantial holder | Thu, 14 Aug 2008 |
| Ceasing to be a substantial holder | Thu, 14 Aug 2008 |
| Appendix 3B | Thu, 14 Aug 2008 |
| Notice under Section 708A(5)(e) | Thu, 14 Aug 2008 |
| Circadian completes acquisition of 100% of Vegenics | Thu, 14 Aug 2008 |
| Key strategic US patent granted for angiogenesis inhibitors | Wed, 13 Aug 2008 |
| Final Director`s Interest Notice | Fri, 1 Aug 2008 |
| Resignation of Director - James MacKenzie | Wed, 30 Jul 2008 |
| Circadian to secure 100% ownership of Vegenics | Tue, 15 Jul 2008 |
| Initial Director`s Interest Notice | Wed, 2 Jul 2008 |
| Publication of major role of VEGFR-3 in angiogenesis | Mon, 30 Jun 2008 |
| CIR associate ANP achieves Phase IIa MS trial success | Mon, 30 Jun 2008 |
| Director appointment | Fri, 13 Jun 2008 |
| CIR establishes world class team to develop cancer drugs | Wed, 11 Jun 2008 |
| Corporate Presentation | Wed, 11 Jun 2008 |
| Change in substantial holding | Thu, 29 May 2008 |
| Ceasing to be a substantial holder for MBP | Mon, 12 May 2008 |
| Edward St Consulting to acquire Circadian`s interest in MBP | Mon, 28 Apr 2008 |
| ANP: Placement | Wed, 16 Apr 2008 |
| Antibody manufacturing collaboration with BioInvent Int. AB | Thu, 10 Apr 2008 |
| Ceasing to be a substantial holder | Wed, 12 Mar 2008 |
| Change of Director`s Interest Notice | Tue, 11 Mar 2008 |
| Initial Director`s Interest Notice | Tue, 4 Mar 2008 |
| Final Director`s Interest Notice | Fri, 29 Feb 2008 |
| Director Appointment | Tue, 26 Feb 2008 |
| Appendix 3B | Tue, 19 Feb 2008 |
| Half Yearly Report and Accounts | Thu, 14 Feb 2008 |
| Circadian Technologies - Corporate Presentation (amended) | Thu, 31 Jan 2008 |
| Circadian Technologies - Corporate Presentation | Thu, 31 Jan 2008 |
| Change of Director`s Interest Notice | Wed, 19 Dec 2007 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.